Payne Fletcher

CIK 00016504762 companiesTORONTO

SEC Profile

Transactions

Companies

Filings

CIK

0001650476

Recent Transactions

28 trades

Disposition to Issuer
Aptose Biosciences Inc.$APTOF
Common Shares
2026-06-30$1.72/sh−22→ 0 total
Disposition to Issuer
Aptose Biosciences Inc.$APTOF
Common Shares
2026-06-30$1.72/sh−222→ 0 total
Disposition to Issuer
Aptose Biosciences Inc.$APTOF
Common Stock (Option)
2026-06-30−1,000,000→ 0 total
Disposition to Issuer
Aptose Biosciences Inc.$APTOF
Employee Stock Option (Right to Buy)
2026-06-30−200,000→ 0 total
Disposition to Issuer
Aptose Biosciences Inc.$APTOF
Employee Stock Option (Right to Buy)
2026-06-30−55,000→ 0 total
Award
Aptose Biosciences Inc.$APTOF
Employee Stock Option (Right to Buy)
2024-02-05+55,000→ 55,000 total
Award
Aptose Biosciences Inc.$APTOF
Common Shares
2023-01-19+100,000→ 100,000 total
Award
Aptose Biosciences Inc.$APTOF
Employee Stock Option (Right to Buy)
2023-01-19+200,000→ 200,000 total
Purchase
Aptose Biosciences Inc.$APTOF
Common Shares
2022-09-19$0.68/sh+10,000→ 10,000 total
Award
Aptose Biosciences Inc.$APTOF
Common Stock
2022-06-27+1,000,000→ 1,000,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-08-12$6.51/sh+1,180→ 3,744 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-02-11$7.04/sh+1,002→ 3,731 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2019-02-04−1,503→ 73,497 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-02-04$4.63/sh+1,503→ 3,230 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2019-01-24+38,000→ 38,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-07-30+25,000→ 25,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-03-26−59→ 74,941 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2018-03-26$4.63/sh+59→ 59 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-12+26,000→ 26,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2017-07-11+75,000→ 75,000 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2015-12-17$2.00/sh+10,000→ 25,032 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+28,572→ 28,572 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+28,572→ 28,572 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+71,428→ 71,428 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-08-20+7,320→ 7,320 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2015-08-20+15,032→ 15,032 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-08-20+14,325→ 14,325 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-08-20+2,440→ 2,440 total

Companies

Recent Filings

Address

C/O APTOSE BIOSCIENCES INC. 251 CONSUMERS ROAD, SUITE 1105

TORONTO, M2J 4R3

View on SEC.gov